Would You Use It With a Seal of Approval? Important Attributes of 2,4-Dinitrophenol (2,4-DNP) as a Hypothetical Pharmaceutical Product

Abstract

Background2,4-Dinitrophenol (2,4-DNP) is an effective but highly dangerous fat burner, not licensed for human consumption. Death cases reported for 2,4-DNP overdose, particularly among young adults, have raised concerns about the ineffective regulatory control, lack of education and risks associated with impurity, and the unknown concentration of 2,4-DNP purchased on the Internet.MethodsUsing a sequential mixed method design and based on a hypothetical scenario as if 2,4-DNP was a licensed pharmaceutical drug, first we conducted a qualitative study to explore what product attributes people consider when buying a weight-loss aid. Focus group interviews with six females and three males (mean age = 21.6 ± 1.8 years) were audiorecorded, transcribed verbatim, and subjected to thematic analysis. Sixteen attributes were identified for the Best–Worst Scale (BWS) in the quantitative survey with 106 participants (64% female, mean age = 27.1 ± 11.9 years), focusing on 2,4-DNP. Demographics, weight satisfaction, and risk for eating disorder data were collected.ResultsIn contrast to experienced users such as bodybuilders, our study participants approached 2,4-DNP cautiously. Attributes of 2,4-DNP as a hypothetical weight-loss drug comprised a range of desirable and avoidable features. Of the 16 selected attributes, BWS suggested that long-term side effects were the most and branding was the least important attribute. Effectiveness and short-term side effects were also essential. Those in the >25 year group showed least concerns for legality. Neutral BWS scores for cost, treatment, degree of lifestyle changes required, and specificity required for the hypothetical weight-loss drug to be effective were likely caused by disagreement about their importance among the participants, not indifference.ConclusionWith advances in research, 2,4-DNP as a pharmaceutical drug in the future for treating neurodegenerative diseases and potentially for weight loss is not inconceivable. Caution is warranted for interpreting the BWS scores. Owing to the difference in what data represent at individual vs. population levels, with pooled data, the method correctly identifies attributes by which most people are satisfied but misrepresents attributes that are individually very important but not universally agreed. Whilst this may be an advantage in marketing applications, it limits the utility of BWS as a research tool.

Neuronal AMPK coordinates mitochondrial energy sensing and hypoxia resistance inC. elegans

“…In addition, once pharmacologic agents act to decrease PMF, they cannot be reversed. Therefore, using drugs to decrease the PMF is dangerous due to narrow therapeutic windows and lack of tissue selectivity 19–21 . This difficulty in developing PMF therapy highlights the need for spatiotemporal control in experimental models to understand how decreasing the PMF provides stress resistance.…”

“…Therefore, using drugs to decrease the PMF is dangerous due to narrow therapeutic windows and lack of tissue selectivity. [19][20][21] This difficulty in developing PMF therapy highlights the need for spatiotemporal control in experimental models to understand how decreasing the PMF provides stress resistance. How and where the metabolic state of an organism is sensed, and how that translates to physiologic changes remains unclear.…”

One Does Not Fit All: European Study Shows Significant Differences in Value-Priorities in Clean Sport

“…The consistent low ranking of "excellence is performance" is a perplexing outcome which warrants further exploration. From the research point of view, values in the middle ranks also present an intriguing question, namely if the reason for a more neutral ranking is caused by indifference, or more likely, large disagreement at the individual level as observed previously with the BWS method (Bleasdale et al, 2018).…”

Mitochondrial Uncoupling: A Fine-Tuning Knob for Mitochondria-Targeting Therapeutics for Coronary Artery Disease

“…At the same time, this process breaks down carbohydrates and fats, allowing energy from cellular respiration to be released as heat. The excess heat production led to uncontrolled toxic hyperthermia associated with significant morbidity and mortality 6) . The history of DNP becomes an important lesson that clinical application of a mitochondrial uncoupler needs finetuned dosing regimens that spare adverse effects.…”